Research & Development
As a global pharmaceutical company, the discovery and development of innovative medicines is fundamental to our continued growth and success. Our blueprint for innovation is tailored to accelerate the delivery of breakthrough medicines to the patients we serve by integrating research, pre-clinical and early clinical development, translational medicine and external partnering functions. This fusion of expertise combined with a dynamic research approach and an increased emphasis on external collaborations means we can effectively incubate the most creative ideas and be among the pioneers in emerging fields of medicine.
Open Innovation
Boehringer Ingelheim has long had a progressive approach to harnessing scientific and innovation excellence. The unifying principle of working together across the innovation community to advance R&D is one that is injecting new power into the drug discovery engine.
-
Open Innovation at Boehringer Ingelheim
Open Innovation
-
Public-Private Partnerships
Open Innovation
-
Fostering Scientific Excellence
Open Innovation
-
Scientific Crowdsourcing
Open Innovation